|
|
Volumn 40, Issue 8, 2002, Pages 387-388
|
|
Clinical and pharmacokinetic study with liposomal doxorubicin (DL-1) in patients with advanced metastatic cancer - Results from a phase-I study
a
|
|
Author keywords
Doxorubicin; Liposomes; Phase I study
|
|
Indexed keywords
ANTHRACYCLINE;
CHOLESTEROL;
DOXORUBICIN;
DOXORUBICIN DERIVATIVE;
DOXORUBICINOL;
LIPOSOME;
PHOSPHATIDYLCHOLINE;
TLCD 99;
UNCLASSIFIED DRUG;
ADULT;
ADVANCED CANCER;
AGED;
AREA UNDER THE CURVE;
ARTICLE;
BLOOD SAMPLING;
CANCER PATIENT;
CARDIOTOXICITY;
CLINICAL ARTICLE;
CLINICAL STUDY;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DRUG BLOOD LEVEL;
DRUG CLEARANCE;
DRUG DELIVERY SYSTEM;
DRUG DISTRIBUTION;
DRUG EFFICACY;
DRUG FORMULATION;
DRUG HALF LIFE;
DRUG INDUCED DISEASE;
DRUG METABOLISM;
DRUG MIXTURE;
DRUG SYNTHESIS;
DRUG TARGETING;
DRUG TOXICITY;
ENCAPSULATION;
FEMALE;
FEVER;
HUMAN;
MALE;
METASTASIS;
NEUTROPENIA;
PHARMACOLOGICAL PARAMETERS;
PHASE 1 CLINICAL TRIAL;
THROMBOCYTOPENIA;
VOMITING;
|
|
EID: 0036326392
PISSN: 09461965
EISSN: None
Source Type: Journal
DOI: 10.5414/CPP40387 Document Type: Article |
|
Times cited : (1)
|
|
References (5)
|
